UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008668 |
|---|---|
| Receipt number | R000010187 |
| Scientific Title | Phase II study of XELIRI and bevacizumab as second-line therapy in patients with metastatic colorectal cancer |
| Date of disclosure of the study information | 2012/08/11 |
| Last modified on | 2021/08/23 11:48:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/08/10 17:26:19 | ||
| 2 | Update | 2015/02/12 11:39:30 | Organization TEL Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Organization1 Tel1 |
|
| 3 | Update | 2021/08/23 11:48:55 | Recruitment status Date of IRB Last follow-up date |
